Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


06.02.2017

2 Am J Dermatopathol
2 Ann Surg Oncol
1 Anticancer Res
1 Biochem Biophys Res Commun
1 BMC Ophthalmol
1 Br J Dermatol
1 Cancer Lett
1 J Am Acad Dermatol
2 J Clin Oncol
1 J Invest Dermatol
2 Melanoma Res
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. CINTRA LOPES CARAPETO F, Neves Comodo A, Germano A, Pereira Guimaraes D, et al
    Marker Protein Expression Combined With Expression Heterogeneity is a Powerful Indicator of Malignancy in Acral Lentiginous Melanomas.
    Am J Dermatopathol. 2017;39:114-120.
    PubMed     Text format     Abstract available

  2. HSIEH R, Nico MM, Camillo CM, Oliveira KK, et al
    Mutational Status of NRAS and BRAF Genes and Protein Expression Analysis in a Series of Primary Oral Mucosal Melanoma.
    Am J Dermatopathol. 2017;39:104-110.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. PARK TS, Phan GQ, Yang JC, Kammula U, et al
    Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 31. doi: 10.1245/s10434-017-5768.
    PubMed     Text format     Abstract available

  4. CROOKES TR, Scolyer RA, Lo S, Drummond M, et al
    Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 27. doi: 10.1245/s10434-016-5723.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. NGUYEN AH, Detty SQ, Agrawal DK
    Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Anticancer Res. 2017;37:1-7.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. LIU Y, Cai P, Wang N, Zhang Q, et al
    Combined blockade of Tim-3 and MEK inhibitor enhances the efficacy against melanoma.
    Biochem Biophys Res Commun. 2017 Jan 26. pii: S0006-291X(17)30187.
    PubMed     Text format     Abstract available


    BMC Ophthalmol

  7. FEA AM, Briamonte C, Aragno V, Grignolo FM, et al
    Vascularized solid iris lesion in a 3 year old child: 5 years of follow up.
    BMC Ophthalmol. 2016;16:89.
    PubMed     Text format     Abstract available


    Br J Dermatol

  8. WOLNER ZJ, Marghoob AA, Pulitzer MP, Postow MA, et al
    A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15354.
    PubMed     Text format     Abstract available


    Cancer Lett

  9. PEARLMAN RL, Montes de Oca MK, Pal HC, Afaq F, et al
    Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.
    Cancer Lett. 2017 Jan 25. pii: S0304-3835(17)30070.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. SHIN TM, Shaikh WR, Etzkorn JR, Sobanko JF, et al
    Clinical and pathologic factors associated with subclinical spread of invasive melanoma.
    J Am Acad Dermatol. 2017 Jan 28. pii: S0190-9622(16)31165.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. BULLOCH KJ, Narayan D, Ariyan S, Gould Rothberg BE, et al
    Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  12. AGARWALA SS, Lee SJ, Yip W, Rao UN, et al
    Phase III Randomized Study of 4 Weeks of High-Dose Interferon-alpha-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Rese
    J Clin Oncol. 2017 Jan 30:JCO2016702951. doi: 10.1200/JCO.2016.70.2951.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  13. TROUSIL S, Chen S, Mu C, Shaw FM, et al
    Phenformin enhances the efficacy of ERK inhibition in NF1-mutant melanoma.
    J Invest Dermatol. 2017 Jan 28. pii: S0022-202X(17)30052.
    PubMed     Text format     Abstract available


    Melanoma Res

  14. RIBERO S, Longo C, Specchio F, Piana S, et al
    Lymph nodes' capsular naevi are associated with high naevus count in melanoma patients: a case-control study.
    Melanoma Res. 2017 Feb 1. doi: 10.1097/CMR.0000000000000328.
    PubMed     Text format     Abstract available

  15. PELLEGRINI C, Maturo MG, Martorelli C, Suppa M, et al
    Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
    Melanoma Res. 2017 Jan 31. doi: 10.1097/CMR.0000000000000323.
    PubMed     Text format     Abstract available


    PLoS One

  16. LABERGE GS, Duvall E, Grasmick Z, Haedicke K, et al
    A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis.
    PLoS One. 2017;12:e0168581.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. ADAR S, Hu J, Lieb JD, Sancar A, et al
    Genome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis.
    Proc Natl Acad Sci U S A. 2016;113:E2124-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: